The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
VMAT2 knockout mice: Heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity
Open accessAbstract
The brain vesicular monoamine transporter (VMAT2) pumps monoamine neurotransmitters and Parkinsonism-inducing dopamine neurotoxins such as 1-methyl-4-phenyl-phenypyridinium (MPP + ) from neuronal cytoplasm into synaptic vesicles, from which amphetamines cause their release. Amphetamines and MPP + each also act at nonvesicular sites, providing current uncertainties about the contributions of vesicular actions to their in vivo effects. To assess vesicular contributions to amphetamine-induced locomotion, amphetamine-induced reward, and sequestration and resistance to dopaminergic neurotoxins, we have constructed transgenic VMAT2 knockout mice. Heterozygous VMAT2 knockouts are viable into adult life and display VMAT2 levels one-half that of wild-type values, accompanied by smaller changes in monoaminergic markers, heart rate, and blood pressure. Weight gain, fertility, habituation, passive avoidance, and locomotor activities are similar to wild-type littermates. In these heterozygotes, amphetamine produces enhanced locomotion but diminished behavioral reward, as measured by conditioned place preference. Administration of the MPP + precursor N -methyl-4-phenyl-1,2,3,6-tetrahydropyridine to heterozygotes produces more than twice the dopamine cell losses found in wild-type mice. These mice provide novel information about the contributions of synaptic vesicular actions of monoaminergic drugs and neurotoxins and suggest that intact synaptic vesicle function may contribute more to amphetamine-conditioned reward than to amphetamine-induced locomotion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476
Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
Soriano, P., Montgomery, C., Geske, R., & Bradley, A. (1991) · Cell · doi:10.1016/0092-8674(91)90499-o · Cited by 2,016
Neurotransmitter Transporters: Recent Progress
Amara, S. G., & Kuhar, M. J. (1993) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.16.030193.000445 · Cited by 1,082
Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter
Pacholczyk, T., Blakely, R. D., & Amara, S. G. (1991) · Nature · doi:10.1038/350350a0 · Cited by 933
Cloning and expression of a functional serotonin transporter from rat brain
Blakely, R. D., Berson, H. E., Fremeau, R. T., Caron, M. G., Peek, M. M., Prince, H. K., & Bradley, C. C. (1991) · Nature · doi:10.1038/354066a0 · Cited by 831
Amphetamine: Effects on Catecholamine Systems and Behavior
Seiden, L. S., Sabol, K. E., & Ricaurte, G. A. (1993) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.33.040193.003231 · Cited by 827
Alonso, S., Minty, A., Bourlet, Y., & Buckingham, M. (1986) · Journal of Molecular Evolution · doi:10.1007/bf02100994 · Cited by 643
Przedborski, S., Jackson-Lewis, V, Yokoyama, R., Shibata, T., Dawson, V. L., & Dawson, T. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4565 · Cited by 624
Self-citationJackson-Lewis, V., Jakowec, M., Burke, R. E., & Przedborski, S. (1995) · Neurodegeneration · doi:10.1016/1055-8330(95)90015-2 · Cited by 609
Self-citationA cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter
Liu, Y. (1992) · Cell · doi:10.1016/0092-8674(92)90425-c · Cited by 594
Cloning and Expression of a Cocaine-Sensitive Dopamine Transporter Complementary DNA
Shimada, S., Kitayama, S., Lin, C.-L., Patel, A., Nanthakumar, E., Gregor, P., Kuhar, M., & Uhl, G. (1991) · Science · doi:10.1126/science.1948034 · Cited by 586
Self-citationBeta Adrenergic Receptor Binding in Membrane Preparations from Mammalian Brain
BYLUND, D. B., & SNYDER, S. H. (1976) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10785-2 · Cited by 568
Rate of cell death in parkinsonism indicates active neuropathological process
McGeer, P. L., Itagaki, S., Akiyama, H., & McGeer, E. G. (1988) · Annals of Neurology · doi:10.1002/ana.410240415 · Cited by 556
Rudnick, G., & Wall, S. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1817 · Cited by 535
Sora, I., Takahashi, N., Funada, M., Ujike, H., Revay, R. S., Donovan, D. M., Miner, L. L., & Uhl, G. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1544 · Cited by 523
Self-citationExpression cloning of a reserpine-sensitive vesicular monoamine transporter.
Erickson, J. D., Eiden, L. E., & Hoffman, B. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10993 · Cited by 487
A Simple Genetic Basis for a Complex Psychological Trait in Laboratory Mice
Flint, J., Corley, R., DeFries, J. C., Fulker, D. W., Gray, J. A., Miller, S., & Collins, A. C. (1995) · Science · doi:10.1126/science.7660127 · Cited by 438
Sulzer, D., & Rayport, S. (1990) · Neuron · doi:10.1016/0896-6273(90)90339-h · Cited by 389
Johnson, R. G. (1988) · Physiological Reviews · doi:10.1152/physrev.1988.68.1.232 · Cited by 323
The Biochemical Basis of Neuropharmacology
Faden, A. I. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530350019005 · Cited by 320
Dopamine transporter immunoreactivity in rat brain
Freed, C., Revay, R., Vaughan, R. A., Kriek, E., Grant, S., Uhl, G. R., & Kuhar, M. J. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903590211 · Cited by 246
Self-citationThe Neuropharmacological Basis of Reward
ALTAMURA, A. C. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.7.976 · Cited by 234
Uhl, G. R., Hedreen, J. C., & Price, D. L. (1985) · Neurology · doi:10.1212/wnl.35.8.1215 · Cited by 230
Self-citationDopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons
Uhl, G. R., Walther, D. M., Mash, D. C., Faucheux, B. A., & Javoy-Agid, F. (1994) · Annals of Neurology · doi:10.1002/ana.410350421 · Cited by 179
Self-citationExtra‐ and Intracellular pH During Near‐Complete Forebrain Ischemia in the Rat
von Hanwehr, R., Smith, M., & Siesjö, B. K. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb12973.x · Cited by 147
Dopamine transporter mRNA: dense expression in ventral midbrain neurons
Shimada, S., Kitayama, S., Walther, D. M., & Uhl, G. R. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90220-6 · Cited by 140
Self-citationTerai, M., Hidaka, K., & Nakamura, Y. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90516-5 · Cited by 127
Biochemistry and Molecular Biology of the Vesicular Monoamine Transporter from Chromaffin Granules
Henry, J., Botton, D., Sagné, C., Isambert, M. F., Desnos, C., Blanchard, V., Raisman‐Vozari, R., Krejci, É., Massoulié, J., & Gasnier, B. (1994) · Journal of Experimental Biology · doi:10.1242/jeb.196.1.251 · Cited by 122
Characterization of [3H]Paroxetine Binding in Rat Brain
Marcusson, J. O., Bergstrom, M., Eriksson, K., & Ross, S. B. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb02479.x · Cited by 118
Retained cocaine conditioned place preference in D1 receptor deficient mice
Miner, L. L., Drago, J., Chamberlain, P. M., Donovan, D. M., & Uhl, G. R. (1995) · Neuroreport · doi:10.1097/00001756-199511270-00011 · Cited by 112
Self-citationDihydrotetrabenazine Binding and Monoamine Uptake in Mouse Brain Regions
Scherman, D. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb04506.x · Cited by 100
Kitayama, S., Shimada, S., & Uhl, G. R. (1992) · Annals of Neurology · doi:10.1002/ana.410320120 · Cited by 95
Self-citationPrimary structure of mouse tyrosine hydroxylase deduced from its cDNA
Ichikawa, S., Sasaoka, T., & Nagatsu, T. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)90472-j · Cited by 53
Ujike, H., Akiyama, K., Nishikawa, H., Onoue, T., & Otsuki, S. (1991) · Brain Research · doi:10.1016/0006-8993(91)90503-n · Cited by 42
Self-citationLiu, L., Xu, W., Harrington, K. A., & Emson, P. C. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90282-8 · Cited by 24
Naini, A., Vontzalidou, E., & Cote, L. J. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.2.247 · Cited by 14
Cited by
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Self-citationThe developmental role of serotonin: news from mouse molecular genetics
Gaspar, P., Cases, O., & Maroteaux, L. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1256 · Cited by 1,297
Tzschentke, T. M. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00060-4 · Cited by 1,266
Blum, D., Torch, S., Lambeng, N., Nissou, M.-F., Benabid, A.-L., Sadoul, R., & Verna, J.-M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00003-x · Cited by 1,246
Mechanisms of neurotransmitter release by amphetamines: A review
Sulzer, D., Sonders, M. S., Poulsen, N. W., & Galli, A. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.003 · Cited by 1,209
Metadata
- Authors
- Takahashi, N., Miner, L. L., Sora, I., Ujike, H., Revay, R. S., Kostic, V., Jackson-Lewis, V., Przedborski, S., & Uhl, G. R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1997-09-02
- Volume
- 94
- Issue
- 18
- Pages
- 9938-9943
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2011854027
- Cited by
- 429
- References
- 36
- FWCI
- 7.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.